Skip to main content
. 2019 Sep 2;39(2):368–384. doi: 10.1038/s41388-019-0993-1

Fig. 2.

Fig. 2

β3-AR blockade modulates S1P signaling in human neuroblastoma BE(2)C cells. a RT-PCR of human NB BE(2)C cell line treated with 1 μM SR59230A for 24 h. Change of mRNA expression levels of receptors (S1P1, S1P2, S1P3), metabolic enzymes (SK1, SK2, SPL) and transporter (Spns2) of S1P are reported as mean ± SD of three independent experiments performed in triplicate, using the 2^(-ΔΔCt) method as described in Methods section. Data were normalized to β-actin RNA expression and values of treated samples reported as fold change over control, set as 1. Significance was calculated by Unpaired t-test analysis with equal SD (**P < 0.01). b WB and relative densitometric quantification analysis, showing protein expression levels of SK1, SK2, and S1P2 in NB BE(2)C cell line after 24 h of 1 μM SR59230A treatment. Results were normalized to the expression of β-actin and reported as mean ± SD, fold change over control, set as 1. Blots are representative of three independent experiments. Significance was calculated by Unpaired t-test analysis with equal SD (*P < 0.05, ***P < 0.001). c WB and relative densitometric quantification analysis, showing protein expression levels of β2-AR, β3-AR, SK2 and S1P2 in NB BE(2)C cell line after molecular silencing of β2- and β3-AR. Results were normalized to the expression of β-actin and reported as mean ± SD, fold change over control, set as 1. Blots are representative of three independent experiments. Significance was calculated by one-way ANOVA analysis followed by Bonferroni’s post hoc test (ns = not significant, *P < 0.05, **P < 0.01, ****P < 0.0001)